TrialThe Journal of experimental medicine2008

Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets.

Claude Sportès et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.